Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Millennium Clinical Research, INC
mi
from
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Millennium Clinical Research, INC
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Regenerate Clinical Trials
mi
from
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Regenerate Clinical Trials
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Life Medical Center & Research, Inc
mi
from
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Life Medical Center & Research, Inc
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Vista Health Research, LLC
mi
from
Miami, FL
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Vista Health Research, LLC
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Elias Research
mi
from
Troy, MI
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Elias Research
mi
from
Troy, MI
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Montana Medical Research/Elias Research Assoc.
mi
from
Missoula, MT
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Montana Medical Research/Elias Research Assoc.
mi
from
Missoula, MT
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
L&C Professional Medical Research Institute
mi
from
Hazleton, PA
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
L&C Professional Medical Research Institute
mi
from
Hazleton, PA
Click here to add this to my saved trials
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Sun Research Institute
mi
from
San Antonio, TX
Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis
An Open-Label Safety Study to Assess the Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Topical Treatment With Halobetasol Propionate 0.05% Topical Spray (Sun Pharmaceuticals Industries Limited) in Patients With Moderate to Severe Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Sun Research Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  12/31/1969
Ps0016 704
mi
from
Bexley, OH
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 12/31/1969
Ps0016 704
mi
from
Bexley, OH
Click here to add this to my saved trials
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  12/31/1969
Ps0013 003
mi
from
Carlton,
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 12/31/1969
Ps0013 003
mi
from
Carlton,
Click here to add this to my saved trials
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated:  12/31/1969
Ps0016 701
mi
from
High Point, NC
This is a Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque Psoriasis.
A Multicenter, 48-week, Open-label Extension Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis.
Status: Enrolling
Updated: 12/31/1969
Ps0016 701
mi
from
High Point, NC
Click here to add this to my saved trials
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy
Hypothesis: Skin Barrier Dysfunction With Altered Expression of Skin Barrier Proteins and Lipids Predicts Early Food Sensitizations in Infants at High Risk of Atopy
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 35
mi
from
Anniston, AL
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 35
mi
from
Anniston, AL
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 21
mi
from
Birmingham, AL
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 21
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 24
mi
from
Oceanside, CA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 24
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 34
mi
from
San Diego, CA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 34
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 27
mi
from
Santa Monica, CA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 27
mi
from
Santa Monica, CA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 1
mi
from
Miami, FL
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 1
mi
from
Miami, FL
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 14
mi
from
Pinellas Park, FL
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 14
mi
from
Pinellas Park, FL
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 22
mi
from
Tampa, FL
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 22
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 29
mi
from
Snellville, GA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 29
mi
from
Snellville, GA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 17
mi
from
New Albany, IN
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 17
mi
from
New Albany, IN
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 32
mi
from
Louisville, KY
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 32
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 11
mi
from
Warren, MI
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 11
mi
from
Warren, MI
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 15
mi
from
Fridley, MN
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 15
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 25
mi
from
Saint Joseph, MO
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 25
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 26
mi
from
Albuquerque, NM
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 26
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 20
mi
from
New York, NY
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 20
mi
from
New York, NY
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 30
mi
from
Stony Brook, NY
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 30
mi
from
Stony Brook, NY
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 28
mi
from
Charlotte, NC
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 28
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 12
mi
from
Beachwood, OH
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 12
mi
from
Beachwood, OH
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 5
mi
from
Cincinnati, OH
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 5
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 3
mi
from
Oklahoma City, OK
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 3
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 8
mi
from
Johnston, RI
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 8
mi
from
Johnston, RI
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 6
mi
from
Spartanburg, SC
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 6
mi
from
Spartanburg, SC
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 9
mi
from
Nashville, TN
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 9
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 19
mi
from
Austin, TX
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 19
mi
from
Austin, TX
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 4
mi
from
Plano, TX
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 4
mi
from
Plano, TX
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 2
mi
from
San Antonio, TX
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 2
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 13
mi
from
Richmond, VA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 13
mi
from
Richmond, VA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 10
mi
from
Spokane, WA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 10
mi
from
Spokane, WA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 18
mi
from
Laguna Hills, CA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 18
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Ralexar Investigational Site 23
mi
from
Los Angeles, CA
A Study in Subjects With Moderate Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Bilateral, Vehicle-Controlled Study of the Safety and Efficacy of ALX-101 Topical Gel Administered Twice Daily in Adult and Adolescent Subjects With Moderate Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Ralexar Investigational Site 23
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Rady Children's Hospital - San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
National Jewish Health
mi
from
Denver, CO
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
National Jewish Health
mi
from
Denver, CO
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Northwestern University Department of Dermatology
mi
from
Chicago, IL
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Northwestern University Department of Dermatology
mi
from
Chicago, IL
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Wake Research Associates, LLC
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Penn State Hershey Medical Center
mi
from
Hershey, PA
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated:  12/31/1969
Texas Dermatology and Laser Specialist Clinical Research
mi
from
San Antonio, TX
A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
An Open-Label, Pilot Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis
Status: Enrolling
Updated: 12/31/1969
Texas Dermatology and Laser Specialist Clinical Research
mi
from
San Antonio, TX
Click here to add this to my saved trials